John Rothman

John Rothman

Chief Tech/Sci/R&D Officer at RIZE ONCOLOGY INC.
77 year
Health Technology
Consumer Services

Profile

John M.
Rothman
is Chief Scientific Officer at Rize Oncology, Inc. since 2025.
Former positions include Senior Director at Schering-Plough Canada, Inc., EVP-Clinical & Scientific Operations at Advaxis, Inc. from 2011 to 2013, Chief Scientific Officer at Racura Oncology Ltd., and Executive Vice President-Product Development at Tyme Technologies, Inc. from 2020 to 2022.
Education includes a doctorate from Tulane University School of Medicine.

John Rothman active positions

CompaniesPositionStart
RIZE ONCOLOGY INC. Chief Tech/Sci/R&D Officer 09/01/2025

Former positions of John Rothman

CompaniesPositionEnd
TYME TECHNOLOGIES, INC. Corporate Officer/Principal 01/02/2022
RACURA ONCOLOGY LTD Chief Tech/Sci/R&D Officer 01/10/2019
AYALA PHARMACEUTICALS, INC. Chief Operating Officer 09/12/2011
Director/Board Member -
See the detail of John Rothman's experience

Education of John Rothman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

24

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology